Ключові слова
епідеміологія
етіологія
класифікація
молекулярна біологія
Як цитувати
Анотація
В статті розглянуті проблеми, що постають перед патоморфологом, який має справу з герміногенними пухлинами яєчок, з точки зору епідеміології, етіології, молекулярно-генетичних особливостей даних пухлин і їх сучасної номенклатури.Посилання
Trabert B., Chen J., Devesa S.S., Bray F., McGlynn K.A. (2015). International patterns and trends in testicular cancer incidence, overalland by histologic subtype, 1973–2007. Andrology. 3: 4–12.
Burova E.A., Bulanov A.A., Tryakin A.A., Fedyanin M.Y., Tyulyandin S.A., Matveyev V.B. (2015). Lechenie seminomy yaichka 1 stadii [Treatment for stage I testicular seminoma]. Onkourolohiia – Cancer Urology. 3: 7–11.
Woodward P.J., Heidenreich A., Looijenga L.H.J. (2004) Germ cell tumours. In: Eble, J.N., Sauter, G., Epstein, J.I., Sesterhenn, I.A. (eds.) WHO classification of tumours. VI. Pathology and genetics of tumours of the urinary system and genital organs – Pathology and genetics of the urinary system and male genital organ. Lyon: IARC Press. 221–249.
Stang A., Trabert B., Wentzensen N., Cook M.B., Rusner C., Oosterhuis J.W. et al. (2012). Gonadal and extragonadal germ cell tumours in the United States, 1973-2007. Int. J. Androl. 35: 616–625.
Bray F., Richiardi L., Ekbom A., Pukkala E., Cuninkova M., Møller H. (2006). Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int. J. Cancer. 118: 3099–3111.
Znaor A., Lortet-Tieulent J., Laversanne M., Jemal A., Bray F. (2015). International testicular cancer incidence trends: generational transitions in 38 countries 1900-1990. Cancer Causes Control. 26: 151–158.
Imyanitov E.N. (2006). Epidemiologiya i biologiya germinogennyh opuholej [Epidemiology and biology of germinal cell tumors]. Prakticheskaia onkolohiia – Practical Oncology. 7: 1–5.
Levine H., Afek A., Shamiss A., Derazne E., Tzur D., Zavdy O. et al. (2013). Risk of germ cell testicular cancer according to origin: a migrant cohort study in 1, 100,000 Israeli men. Int. J. Cancer. 132: 1878–1885.
Montgomery S.M., Granath F., Ehlin A., Sparén P., Ekbom A. (2005). Germ-cell testicular cancer in offspring of Finnish immigrants to Swede. Cancer Epidemiol. Biomarkers. Prev. 14: 280–282.
Rijlaarsdam M.A., Looijenga L.H. (2014). An oncofetal and developmental perspective on testicular germ cell cancer. Semin. Cancer Biol. 29: 59–74.
Albers P., Albrecht W., Algaba F. (2005). Guidelines on Testicular Cancer. Europ. Urol. 48: 885–894.
Dohle G.R., Colpi G.M., Hargreave T.B., Papp G.K., Jungwirth A., Weidner W. (2005). EAU Guidelines on Male Infertility. Europ. Urol. 48: 703–711.
Heimdal K., Olsson H., Tretli S., Flodgren P., Børresen A.L., Fossa S.D. (1996). Familial testicular cancer in Norway and southern Sweden. Br. J. Cancer. 73: 964–969.
Hemminki K., Chen B. (2006). Familial risks in testicular cancer as aetiological clues. Int. J. Androl. 29: 205–210.
Sonneveld D.J., Sleijfer D.T., Schrafford Koops H., Sijmons R.H., van der Graaf W.T., Sluiter W.J. et al. (1999). Familial testicular cancer in a single-center population. Eur. J. Cancer. 35: 1368–1373.
Westergaard T., Olsen J.H., Frisch M., Kroman N., Nielsen J.W., Melbye M. (1996). Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population-based study. Int. J. Cancer. 66: 627–631.
Greene M.H., Mai P.L., Loud J.T., Pathak A., Peters J.A., Mirabello L. et al. (2015). Familial testicular germ cell tumors (FTGCT) – overview of a multidisciplinary etiologic study. Andrology. 3: 47–58.
Czene K., Lichtenstein P., Hemminki K. (2002). Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int. J. Cancer. 99: 260–266.
Ruark E., Seal S., McDonald H., Zhang F., Elliot A., Lau K. et al. (2013). Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. Nat. Genet. 45: 686–689.
Swerdlow A.J., De Stavola B.L., Swanwick M.A., Maconochie N.E. (1997). Risks of breast and testicular cancers in young adult twins in England and Wales: evidence on prenatal and genetic aetiology. Lancet. 350: 1723–1728.
Bosl G.J., Motzer R.J. (1997). Testicular germ-cell cancer. N. Engl. J. Med. 337: 242–253.
Litchfield K., Shipley J., Turnbull C. (2015). Common variants identified in genome-wide association studies of testicular germ cell tumour: an update, biological insights and clinical application. Andrology. 3: 34–46.
Valberg M., Grotmol T., Tretli S., Veierød M.B., Moger T.A., Aalen O.O. (2014). A hierarchical frailty model for familial testicular germ cell tumors. Am. J. Epidemiol. 179: 499–506.
Nathanson K.L., Kanetsky P.A., Hawes R, Vaughn D.J., Letrero R. et al. (2005). The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am. J. Hum. Genet. 77: 1034–1043.
Lottrup G., Jørgensen A., Nielsen J.E., Jørgensen N., Duno M., Vinggaard A.M. et al (2013). Identification of a novel androgen receptor mutation in a family with multiple components compatible with the testicular dysgenesis syndrome. J. Clin. Endocrinol. Metab. 98: 2223–2229.
Cools M., Pleskacova J., Stoop H., Hoebeke P., Van Laecke E., Drop S.L. et al. (2011). Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,X/46,XY mosaicism. J. Clin. Endocrinol. Metab. 96: 1171–1180.
van der Zwan Y.G., Biermann K., Wolffenbuttel K.P., Cools M., Looijenga L.H. (2015). Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model. Eur. Urol. 67: 692–701.
Chung C.C., Kanetsky P.A., Wang Z., Hildebrandt M.A., Koster R., Skotheim R.I. et al. (2013). Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat. Genet. 45: 680–685.
Koster R., Mitra N., D'Andrea K., Vardhanabhuti S., Chung C.C., Wang Z. et al (2014). Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibilily to testicular germ cell tumors. Hum. Mal. Genet. 23: 6061–6068.
Kratz C.P., Han S.S., Rosenberg P.S., Berndt S.I., Burdett L. et al. (2011). Variants in or near KITLG, BAK 1, DMRT1, and TERT-CLPTM1 L predispose lo familial testicular germ cell tumour. J. Med. Genet. 48: 473–476.
Rapley E.A., Nathanson K.L. (2010). Predisposition alleles for Testicular Genm Cell Tumour. Curr. Opin. Genet. Dev. 20: 225–230.
Västermark Å., Giwercman Y.L., Hagströmer O., Rajpert De-Meyts E., Eberhard J., Ståhl O. et al (2011). Polymorphic variation in the androgen receptor gene: association with risk of testicular germ cell cancer and metastatic disease. Eur. J. Cancer. 47: 413–419.
Strohsnitter W.C., Noller K.L., Hoover R.N., Robboy S.J., Palmer J.R., Titus-Ernstoff L. et al. (2001). Nall. Cancer Inst. 93: 545–551.
Henderson B.E., Ross R., Bernstein L. (1988). Estrogens as a cause of human cancer. Cancer Res. 48: 246–253.
Cook M.B., Akre O., Forman D., Madigan M.P., Richiardi L., McGlynn K.A. (2009). A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer-experiences of the mother. Int. J. Epidemiol. 38: 1532–1542.
Cook M.B., Akre O., Forman D., Madigan M.P., Richiardi L., McGlynn K.A. (2010). A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer-experiences of the son. Int. J. Epidemiol. 39: 1605–1618.
Forman D., Pike M.C., Davey G., Dawson S., Baker K. (1994). Aеtiology of tеstiсular cancer: association with congenital abnormolities, ago etpuberty, inferlifity, and exercise. BMJ. 308: 1393–1399.
Dieckmann K.P., Pichlmeier U. (1997). The prevalence of familial testicular cancer. Cancer. 80(10): 1954–1960.
Baker J.A., Buck G.M., Vena J.E., Moysich K.B. (2005). Fertility patterns prior to testicular cancer diagnosis. Cancer Causes Control. 16: 295–299.
Doria-Rose V.P. Biggs M.L., Weiss N.S. (2005). Subfertility and the risk of testicular germ cell tumors (United States). Cancer Causes Control. 16, 651–656.
Casleren N.J., Looijenga L.H., Dohle G.R. (2009). Testicular microlithiasis and carcinoma in situ overview and proposed clinical guideline. Int. J. Androl. 32: 279–287.
Jorgensen N. (1990). Clinical and biological significance of carcinoma of the testis. Cancer surveys. 9: 287–302.
Vorobiev A.V. (2005). Obzor vazhnejshih sobytij v onkourologii [Review of the most important events in oncologic urology]. Prakticheskaia onkolohiia – Practical Oncology. 6: 55–64.
Dieckmann K.P., Pichlmeier U. (2002). Is risk of testicular cancer related to the body size? Eur. Urol. 42 (6): 564–569.
Gallagher R.P., Huchcroft S., Phillips N., Hill G.B., Coldman A.J., Coppin C. et al. (1995). Physical activity, medical history and risk of testicular cancer. Cancer Causes Control. 66: 398–406.
Bosl G.J., Bajorin D.F., Sheinfeld J. Motzer R.J., Chaganti R.S.K. (2005). Cancer of the Testis. In: De Vita, V.T., Hellman, S., Rosenberg, S.A. (eds.) Cancer Principles & Practice of Oncology. Philadelphia: Baltimore; Lippincott Williams & Wilkins, 1269–1294.
Matveev V.B., Volkova M.I. (2003). Opuholi yaichka i paratestikulyarnyh tkanej [Tumors of testes and paratesticular tissues]. Klinicheskaia onkourolohiia – Clinical oncologic urology: 617–684.
McGlynn K.A., Trabert B. (2012). Adolescent and adult risk factors for testicular cancer. Nat. Rev. Urol. 9: 339–349.
Sharpe R.M., Skakkebaek N.E. (1993). Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet. 341: 1392–1395.
Daling J.R., Doody D.R., Sun X., Trabert B.L., Weiss N.S., Chen C. (2011). Association of marijuana use and the incidence of teslicular germ cell tumors. Cancer. 115: 1215–1223.
Trabert B., Sigurdson A.J., Sweeney A.M., Strom S.S., McGlynn K.A. (1994). Marijuana use and testicular germ cell tumors. Cancer. 117: 848–853.
Forman D., Pike M.C., Davey G., Dawson S., Baker K. (1994). Aеtiology of tеstiсular cancer: association with congenital abnormolities, ago etpuberty, inferlifity, and exercise. BMJ. 308: 1393–1399.
Mostofi F.K. (1998). Histological typing of testis tumours. In: Mostofi, F.K., Sesterhenn, I.A., Sobin, L.H. WHO International Histological Classification of Tumours, 2nd ed. Berlin-Heidelberg-New York-Tokyo: Springer. B-905
WHO (2004). WHO Histological classification of testis tumours. In: Eble, J.N., Sauter, G., Epstein, J.I., Sesterhenn, I.A. (eds.) Pathology & Genetics. Tumours of the urinary system and male genital organs. Lyons: IARC Press, 250–262.
Moch E.H., Humphrey P.A., Ulbright T.M., Reuter V.E. (2016). WHO Сlassification of Tumours of the Urinary System and Male Genital Organs. Lyons: IARC Press, 184–258.
Skakkebaek N.E. (1972). Possible carcinoma-in-situ of the testis. Lancet. 12: 516–517.
Ulbright T.M. (1993). Germ cell neoplasms of the testis. The Am. J. Surg. Pathol. 17: 1075–1091.
Reuter V.E. (2005). Origins and molecular biology of testicular germ cell tumors. Mod. Pathol. 18 (2): 51–60.
Biermann K., Göke F., Nettersheim D., Eckert D., Zhou H., Kahl P. et al. (2007). С-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma. J. Pathol. 213: 311–318.
Coffey J., Linger R., Pugh J., Dudakia D., Sokal M., Easton D.F. et al. (2008). Somatic KIT mutations occur predominanlly in seminoma germ cell tumors and are not predictive of bilateral disease: report of 220 tumors and review of literature. Genes Chromosomes Cancer. 47: 34–42.
Looijenga L.H., de Leeuw H., van Oorschot M., van Gurp R.J., Stoop H., Gillis A.J. et al. (2003). Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. Cancer Res. 63: 7674–7678.
Rapley E.A., Hockley S., Warren W., Johnson L., Huddart R., Crockford G. et al. (2004). Somatic mutations of KIT in familial testicular germ cell tumours. Br. J. Cancer. 90: 2397–2401.
Nielsen H., Nielsen M., Skakkebaek N.E. (1974). The fine structure of possible carcinoma-in-situ in the seminiferous tubules in the testis of four infertile men. Acta Pathol. Microbiоl. Scand. 82: 235–248.
Almstrup K., Hoei-Hansen C.E., Wirkner U., Blake J., Schwager C., Ansorge W. et al. (2004). Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res. 64: 4736–4743.
Hart A.H., Hartley L., Parker K., Ibrahim M., Looijenga L.H., Pauchnik M. et al. (2005). Cancer. 104: 2092–2098.
Looijenga L.H., Stoop H., de Leeuw H.P., de Gouveia Brazao C.A., Gillis A.J., van Roozendaal K.E. et al. (2003). POU5F1 (OCT3/4) identifies cells with pluripotenl potential in human germ cell tumors. Cancer Res. 63: 2244–2250.
Almstrup K., Nielsen J.E., Mlynarska O., Jansen M.T., Jørgensen A., Skakkebæk N.E. et al. (2010). Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells. Br. J. Cancer. 103: 1269–1276.
Wermann H., Stoop H., Gillis A.J., Honecker F., van Gurp R.J., Ammerpohl O. et al. (2010). Global DNA methylation in fetal human germ cells and germ cell tumours: association wilh differentiation and cisplatin resistance. J. Pathol. 221: 433–442.
Rajpert-De Meyts E. (2006). Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum. Reprod. Update. 12: 303–323.
Looijenga L.H., Gillis A.J., Stoop H., Hersmus R., Oosterhuis J.W. (2007). Relevance of microRNAs in normal and malignant development, including human testicular germ cell tumours. Int. J. Androl. 30(4): 304–314.
Harms D. Germ сell тumours of childhood. Report of 170 cases including 59 pure and partial yolk-sac tumours/ D. Harms, U. Janig // Virchows Arch. Pathol. Anat. – 1986. – V. 409. – P. 223–239.
Harms D., Janig U. (1986). Germ сell tumours of childhood. Report of 170 cases including 59 pure and partial yolk-sac tumours. Virchows Arch. Pathol. Anat. 409: 223–239.
Purysko A.S., Leao Filho H.M., Herts B.R. (2012). Radiologic imaging of patients with bladder cancer. Semin. Oneal. 39: 543–558.
True L.D., Otis C.N., Delprado W., Scully R.E., Rosai J. (1988). Spermatocytic seminoma of testis with sarcomatous transformation. A report of five cases. Am. J. Surg. Pathol. 12: 75–82.
Browne C.M., Hime G.R., Koopman P., Loveland K.L. (2005). Genetic basis of human testicular germ cell cancer: insights from the fruitfly and mouse. Cell Tissue Res. 322: 5–19.
Oosterhuis J.W., Looijenga L.H. (2005). Testicular germ-cell tumours in a broader perspective. Nat. Rev. Cancer. 5: 210–222.
Bolen J.W. (1998). Mixed germ cell-sex cord stromal tumor. A gonadal tumor distinct from gonablastoma. Am. J. Surg. Pathol. 75; 565–573.
Sperger J.M., Chen X., Draper J.S., Antosiewicz J.E., Chon C.H., Jones S.B. et al. (2003). Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl. Acad. Sci. USA. 100(23): 13350–13355.
Haskins W.E., Eedala S., Jadhav Y.L., Labhan M.S., Pericherla V.C., Perlman E.J. (2012). Insights on neoplastic stem cells from gel-based proteomics of childhood germ cell tumors. Pediatr. Blood Cancer. 58(5): 722–728.
Bosl G.J., Ilson D.H., Rodriguez E., Motzer R.J., Reuter V.E., Chaganti R.S. (1994). Clinical relevance of the i(12p) marker chromosome in germ cell tumors. J. Natl. Cancer. Inst. 86: 349–355.
Kuczyk M.A., Serth J., Bokemeyer C., Jonassen J., Machtens S., Werner M. et al. (1996). Alterations of the p53 tumour suppressor gene in carcinoma in situ of the testis. Cancer. 78(9): 958–966.
Rajpert-De Meyts E., Kvist M., Skakkebaek N.E. (1996). Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: pathogenetic relevance. Virchows Arch. 428: 133 – 139.
Schopperle W.M., Dewolf W.C. (2007). The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem. Cells. 25(3): 723–730.
Looijenga L.H.J., Gillis A.J.M., Van Putten W.L.J., Oosterhuis J.W. (1993). In situ numeric analysis of centromeric regions of chromosomes 1, 12 and 15 of seminomas, nonseminomatous germ cell tumors, and carcinoma in situ of human testis. Lab. Invest. 68: 211–219.
Rosenberg C., Mostert M.C., Schut T.B., van de Pol M., van Echten J., de Jong B. et al. (1998). Chromosomal constitution of human spermatocytic seminomas: compartive genomic hybridization supported by conventional and interphase cytogenetics. Genes Chromosomes Cancer. 18: 23, 286–291.
Mostert M.С., Rosenberg C., Stoop H., Schuyer M., Timmer A., Oosterhuis W.https://www.ncbi.nlm.nih.gov/pubmed/?term=Looijenga%20L%5BAuthor%5D&cauthor=true&cauthor_uid=10908150 et al. (2000). Comparative genomic and in situ hybridization of germ cell tumors of the infantile testis. Lab. Invest. 80: 1055–1064.
Hamers A., de Jong B., Suijkerbuijk R.F., Geurts van Kessel A., Oosterhuis J.W., van Echten J. et al. (1991). A 46,XY female with mixed gonadal dysgenesis and a 48,XY, + 7, + i(12p) chromosome pattern in a primary gonadal tumor. Cancer Genet Cytogenet. 57: 219–224.
Wilson C., Yang J., Strefford J.C., Summersgill B., Young B.D., Shipley J. et al. (2005). Overexpression of genes on 16q associated with cisplatin resistance of testicular germ cell tumor cell lines. Genes Chromosomes Cancer. 43(2): 211–216.
Kersemaekers A.M., Mayer F., Molier M., van Weeren P.C., Oosterhuis J.W., Bokemeyer C. et al. (2002). Role of p53 and MDM2 in treatment response of human germ cell tumors. J. Clin. Oncol. 6: 1551–1561.
Honecker F., Oosterhuis J.W., Mayer F., Hartmann J.T., Bokemeyer C., Looijenga L.H. (2004). New insights into the pathology and molecular biology of human germ cell tumors. World J. Urol. 22: 15–24.